Neuberger Berman Group
AZN icon

Neuberger Berman Group’s AstraZeneca AZN Stock Holding History

Neuberger Berman Group’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$519M Buy
2,635,014
+155,085
+6% +$29.9M 0.39% 42
2025
Q4 		$456M Sell
2,479,929
-53,838
-2% -$9.44M 0.34% 51
2025
Q3 		$389M Buy
2,533,767
+36,668
+1% +$5.55M 0.28% 70
2025
Q2 		$349M Sell
2,497,099
-507,403
-17% -$71.1M 0.27% 77
2025
Q1 		$442M Buy
3,004,502
+160,469
+6% +$23.2M 0.37% 55
2024
Q4 		$373M Buy
2,844,033
+227,550
+9% +$31.9M 0.3% 68
2024
Q3 		$408M Sell
2,616,483
-86,770
-3% -$14M 0.32% 67
2024
Q2 		$422M Buy
2,703,253
+72,489
+3% +$10.9M 0.35% 60
2024
Q1 		$356M Buy
2,630,764
+1,266,528
+93% +$168M 0.29% 74
2023
Q4 		$184M Buy
1,364,236
+61,260
+5% +$7.96M 0.16% 167
2023
Q3 		$176M Buy
1,302,976
+27,415
+2% +$3.74M 0.16% 165
2023
Q2 		$182M Buy
1,275,561
+36,059
+3% +$5.31M 0.16% 161
2023
Q1 		$172M Sell
1,239,502
-459,643
-27% -$61.8M 0.16% 169
2022
Q4 		$230M Buy
1,699,145
+53,560
+3% +$6.72M 0.23% 120
2022
Q3 		$181M Buy
1,645,585
+56,234
+4% +$7.13M 0.19% 150
2022
Q2 		$210M Sell
1,589,351
-17,337
-1% -$2.27M 0.21% 132
2022
Q1 		$213M Sell
1,606,688
-261,926
-14% -$31.4M 0.18% 155
2021
Q4 		$217M Sell
1,868,614
-192,947
-9% -$22.7M 0.17% 170
2021
Q3 		$247M Buy
2,061,561
+560,561
+37% +$65.3M 0.22% 125
2021
Q2 		$180M Buy
1,501,000
+102,870
+7% +$11.3M 0.16% 194
2021
Q1 		$139M Buy
1,398,130
+859,212
+159% +$86.4M 0.13% 231
2020
Q4 		$53.9M Sell
538,918
-28,738
-5% -$3.04M 0.06% 386
2020
Q3 		$62.2M Sell
567,656
-89,496
-14% -$9.95M 0.07% 317
2020
Q2 		$69.5M Sell
657,152
-40,121
-6% -$4.14M 0.09% 302
2020
Q1 		$62.3M Sell
697,273
-66,663
-9% -$6.28M 0.09% 281
2019
Q4 		$76.2M Buy
763,936
+163
+0% +$15.3K 0.09% 318
2019
Q3 		$68.1M Sell
763,773
-5,278
-0.7% -$458K 0.08% 324
2019
Q2 		$63.5M Sell
769,051
-2,964
-0.4% -$232K 0.08% 349
2019
Q1 		$62.4M Buy
772,015
+313,971
+69% +$24.7M 0.08% 349
2018
Q4 		$34.8M Buy
458,044
+194,091
+74% +$15.2M 0.05% 430
2018
Q3 		$20.9M Buy
263,953
+167,677
+174% +$12.7M 0.02% 636
2018
Q2 		$6.76M Sell
96,276
-2,169
-2% -$156K 0.01% 869
2018
Q1 		$6.88M Buy
98,445
+6,169
+7% +$427K 0.01% 838
2017
Q4 		$6.4M Buy
92,276
+36,034
+64% +$2.43M 0.01% 845
2017
Q3 		$3.81M Buy
56,242
+3,686
+7% +$233K ﹤0.01% 894
2017
Q2 		$3.58M Buy
52,556
+462
+0.9% +$30.2K ﹤0.01% 915
2017
Q1 		$3.24M Sell
52,094
-15,740
-23% -$916K ﹤0.01% 918
2016
Q4 		$3.71M Sell
67,834
-4,196
-6% -$238K 0.01% 901
2016
Q3 		$4.73M Buy
72,030
+6,645
+10% +$434K 0.01% 856
2016
Q2 		$3.95M Buy
65,385
+12,796
+24% +$743K 0.01% 878
2016
Q1 		$2.96M Buy
52,589
+2,234
+4% +$134K ﹤0.01% 928
2015
Q4 		$3.42M Buy
50,355
+2,733
+6% +$179K ﹤0.01% 934
2015
Q3 		$3.03M Buy
47,622
+2,519
+6% +$166K ﹤0.01% 967
2015
Q2 		$2.87M Sell
45,103
-546
-1% -$37.4K ﹤0.01% 1011
2015
Q1 		$3.12M Sell
45,649
-1,524
-3% -$106K ﹤0.01% 1006
2014
Q4 		$3.32M Sell
47,173
-1,529
-3% -$109K ﹤0.01% 1001
2014
Q3 		$3.48M Sell
48,702
-80
-0.2% -$5.86K ﹤0.01% 1020
2014
Q2 		$3.63M Sell
48,782
-647,990
-93% -$46.8M ﹤0.01% 1016
2014
Q1 		$45.2M Sell
696,772
-292,676
-30% -$18.9M 0.05% 440
2013
Q4 		$58.7M Buy
989,448
+38,269
+4% +$2.08M 0.06% 401
2013
Q3 		$49.4M Sell
951,179
-225,765
-19% -$11.3M 0.05% 414
2013
Q2 		$55.7M Buy
+1,176,944
New +$59.9M 0.07% 370

Other funds holding AZN

IA
Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
VAM
Vanguard Asset Management London, Ec4n 8af $117B AUM

Neuberger Berman Group's AZN Position: Q1 2026 in Review

Neuberger Berman Group increased its AstraZeneca (AZN) stake by 6.3% in Q1 2026, buying an estimated $29.9M and bringing the position to 2,635,014 shares worth $519M. The position accounts for 0.39% of the portfolio, ranked #42.

Neuberger Berman Group first reported a position in AZN in Q2 2013 and has held it in 52 quarters since. 1,377 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

  • Neuberger Berman Group held 2,635,014 shares of AstraZeneca worth $519M as of Q1 2026.
  • Neuberger Berman Group bought 155,085 AstraZeneca shares in Q1 2026, an estimated $29.9M.
  • AstraZeneca made up 0.39% of Neuberger Berman Group's portfolio in Q1 2026, its #42 holding.
  • Neuberger Berman Group first reported a position in AstraZeneca in Q2 2013 and has held it in 52 quarters since.
  • 1,377 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on Neuberger Berman Group's 13F filing for Q1 2026, filed 14 May 2026.